Recently, Shanghai Sangon Health Medical Laboratory participated in the external quality assessment (EQA) activity organized by the Clinical Inspection Center of the Ministry of Health for the first time...

On 25-27 April, BBI Life Science Co., Ltd. held an annual result Analyst / fund manager promotion road show of 2017 in Hong Kong, which was attended by the company's CEO Wang Luojia and the company management team ...

In the last few days, Sangon Biotech (Shanghai) Co., Ltd., the whole subsidiaries of BBI Group, has set up the new Branches which supply the services of DNA Synthesis and ....

BBI Life Science (HK: 01035) announced that in 2017, the revenue of the group was approximately RMB 462 million, representing an increase of 31.4%; gross profit was ....

On 10 January 2018, the CEO of the group, Ms. Wang Luojia, accompanied by CTO Dr. Li Wei was invited to attend the Pulse of Asia Conference hosted by DBS Vickers ....